» Articles » PMID: 20974963

Thymic Stromal Lymphopoietin-mediated STAT5 Phosphorylation Via Kinases JAK1 and JAK2 Reveals a Key Difference from IL-7-induced Signaling

Overview
Specialty Science
Date 2010 Oct 27
PMID 20974963
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Thymic stromal lymphopoietin (TSLP) is a type I cytokine that plays essential roles in allergic/inflammatory skin and airway disorders, in helminth infections, and in regulating intestinal immunity. TSLP signals via IL-7Rα and a specific TSLPR subunit that is highly related to the common cytokine receptor γ chain, γ(c). Although TSLP has effects on a broad range of hematopoetic cells and can induce STAT5 phosphorylation, TSLP was reported to not signal via JAK kinases, and the mechanism by which TSLP regulates STAT5 phosphorylation has been unclear. We now demonstrate the role of JAK1 and JAK2 in TSLP-mediated STAT5 phosphorylation in mouse and human primary CD4(+) T cells, in contrast to the known activation of JAK1 and JAK3 by the related cytokine, IL-7. We also show that just as JAK1 interacts with IL-7Rα, JAK2 is associated with TSLPR protein. Moreover, we demonstrate the importance of STAT5 activation for TSLP-mediated survival and proliferation of CD4(+) T cells. These findings clarify the basis for TSLP-mediated signaling and provide an example wherein a cytokine uses JAK1 and JAK2 to mediate the activation of STAT5.

Citing Articles

A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases.

Shi L, Yu M, Jin Y, Chen P, Mu G, Tam S Front Immunol. 2024; 15:1442588.

PMID: 39726595 PMC: 11670205. DOI: 10.3389/fimmu.2024.1442588.


Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps.

De Corso E, Hellings P, Fokkens W, Klimek L, Peters A, Scadding G Curr Allergy Asthma Rep. 2024; 25(1):7.

PMID: 39636450 DOI: 10.1007/s11882-024-01186-2.


IL-7 promotes mRNA vaccine-induced long-term immunity.

Wang L, Wan J, He W, Wang Z, Wu Q, Zhou M J Nanobiotechnology. 2024; 22(1):716.

PMID: 39550592 PMC: 11568559. DOI: 10.1186/s12951-024-02993-5.


Association between bronchial asthma and TSLP gene polymorphism: a systematic review and meta-analysis.

Shrestha A, Pokharel P, Singh H, Shrestha S, Shrestha S, Sedhai Y Ann Med Surg (Lond). 2024; 86(8):4684-4694.

PMID: 39118763 PMC: 11305796. DOI: 10.1097/MS9.0000000000002107.


Potential New Inflammatory Markers in Bronchiectasis: A Literature Review.

Bertuccio F, Baio N, Montini S, Ferroni V, Chino V, Pisanu L Curr Issues Mol Biol. 2024; 46(7):6675-6689.

PMID: 39057040 PMC: 11275576. DOI: 10.3390/cimb46070398.


References
1.
Fujio K, Nosaka T, Kojima T, Kawashima T, Yahata T, Copeland N . Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain. Blood. 2000; 95(7):2204-10. View

2.
Schindler C . Series introduction. JAK-STAT signaling in human disease. J Clin Invest. 2002; 109(9):1133-7. PMC: 150971. DOI: 10.1172/JCI15644. View

3.
Russell S, Johnston J, Noguchi M, Kawamura M, Bacon C, Friedmann M . Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science. 1994; 266(5187):1042-5. DOI: 10.1126/science.7973658. View

4.
Isaksen D, Baumann H, Trobridge P, Farr A, Levin S, Ziegler S . Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol. 1999; 163(11):5971-7. View

5.
Sandberg E, Ma X, He K, Frank S, Ostrov D, Sayeski P . Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. J Med Chem. 2005; 48(7):2526-33. DOI: 10.1021/jm049470k. View